TLR2 signaling in tubular epithelial cells regulates NK cell recruitment in kidney ischemia-reperfusion injury

Journal of Immunology

Volumn 191, Issue 5, 2013, Pages 2657-2664

  Kim, Hye J ^a   Lee, Jong S ^a,b   Kim, Ahra ^b   Koo, Sumi ^a   Cha, Hee J ^a,b   Han, Jae A ^c   Do, Yoonkyung ^c   Kim, Kyung M ^b,d   Kwon, Byoung S ^e   Mittler, Robert S ^b,f   Cho, Hong R ^a,b   Kwon, Byungsuk ^a,b  

^a University of Ulsan College of Medicine   (South Korea)

^b University of Ulsan   (South Korea)

^c Ulsan National Institute of Science and Technology   (South Korea)

^d Dongnam Institute of Radiological and Medical Science   (South Korea)

^e National Cancer Center   (South Korea)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD137 LIGAND; CHEMOKINE RECEPTOR CCR5; TOLL LIKE RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INFLAMMATION; KIDNEY CAPSULE; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; MOUSE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

4-1BB LIGAND; ANIMALS; CHEMOTAXIS, LEUKOCYTE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULES; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2;

EID: 84883378144     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300358     Document Type: Article

References (26)

1. Medzhitov, R. 2008. Origin and physiological roles of inflammation. Nature 454: 428-435.
2. Nathan, C. 2002. Points of control in inflammation. Nature 420: 846-852.
3. Barton, G. M. 2008. A calculated response: control of inflammation by the innate immune system. J. Clin. Invest. 118: 413-420.
4. Leemans, J. C., G. Stokman, N. Claessen, K. M. Rouschop, G. J. Teske, C. J. Kirschning, S. Akira, T. van der Poll, J. J. Weening, and S. Florquin. 2005. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J. Clin. Invest. 115: 2894-2903.
5. Wu, H., G. Chen, K. R. Wyburn, J. Yin, P. Bertolino, J. M. Eris, S. I. Alexander, A. F. Sharland, and S. J. Chadban. 2007. TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest. 117: 2847-2859.
6. Shigeoka, A. A., T. D. Holscher, A. J. King, F.W. Hall,W. B. Kiosses, P. S. Tobias, N. Mackman, and D. B. McKay. 2007. TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways. J. Immunol. 178: 6252-6258.
7. Pulskens, W. P., G. J. Teske, L. M. Butter, J. J. Roelofs, T. van der Poll, S. Florquin, and J. C. Leemans. 2008. Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury. PLoS ONE 3: e3596.
8. Chen, J., R. John, J. A. Richardson, J. M. Shelton, X. J. Zhou, Y. Wang, Q. Q. Wu, J. R. Hartono, P. D. Winterberg, and C. Y. Lu. 2011. Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury. Kidney Int. 79: 288-299.
9. Krüger, B., S. Krick, N. Dhillon, S. M. Lerner, S. Ames, J. S. Bromberg, M. Lin, L. Walsh, J. Vella, M. Fischereder, et al. 2009. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc. Natl. Acad. Sci. USA 106: 3390-3395.
10. Wu, H., J. Ma, P. Wang, T. M. Corpuz, U. Panchapakesan, K. R. Wyburn, and S. J. Chadban. 2010. HMGB1 contributes to kidney ischemia reperfusion injury. J. Am. Soc. Nephrol. 21: 1878-1890.
11. Allam, R., C. R. Scherbaum, M. N. Darisipudi, S. R. Mulay, H. Hägele, J. Lichtnekert, J. H. Hagemann, K. V. Rupanagudi, M. Ryu, C. Schwarzenberger, et al. 2012. Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J. Am. Soc. Nephrol. 23: 1375-1388.
12. Kim, H. J., J. S. Lee, J. D. Kim, H. J. Cha, A. Kim, S. K. Lee, S. C. Lee, B. S. Kwon, R. S. Mittler, H. R. Cho, and B. Kwon. 2012. Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation. Proc. Natl. Acad. Sci. USA 109: E13-E22.
13. Zhang, Z. X., S. Wang, X. Huang, W. P. Min, H. Sun, W. Liu, B. Garcia, and A. M. Jevnikar. 2008. NK cells induce apoptosis in tubular epithelial cells and contribute to renal ischemia-reperfusion injury. J. Immunol. 181: 7489-7498.
14. Li, L., L. Huang, A. L. Vergis, H. Ye, A. Bajwa, V. Narayan, R. M. Strieter, D. L. Rosin, and M. D. Okusa. 2010. IL-17 produced by neutrophils regulates IFN-g-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J. Clin. Invest. 120: 331-342.
15. Rosin, D. L., and M. D. Okusa. 2011. Dangers within: DAMP responses to damage and cell death in kidney disease. J. Am. Soc. Nephrol. 22: 416-425.
16. Jang, H. R., and H. Rabb. 2009. The innate immune response in ischemic acute kidney injury. Clin. Immunol. 130: 41-50.
17. Swamy, M., C. Jamora, W. Havran, and A. Hayday. 2010. Epithelial decision makers: in search of the "epimmunome." Nat. Immunol. 11: 656-665.
18. Tsuboi, N., Y. Yoshikai, S. Matsuo, T. Kikuchi, K. Iwami, Y. Nagai, O. Takeuchi, S. Akira, and T. Matsuguchi. 2002. Roles of Toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J. Immunol. 169: 2026-2033.
19. Vivier, E., E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini. 2008. Functions of natural killer cells. Nat. Immunol. 9: 503-510.
20. Thurman, J. M., A. M. Lenderink, P. A. Royer, K. E. Coleman, J. Zhou, J. D. Lambris, R. A. Nemenoff, R. J. Quigg, and V. M. Holers. 2007. C3a is required for the production of CXC chemokines by tubular epithelial cells after renal ishemia/reperfusion. J. Immunol. 178: 1819-1828.
21. Miura, M., X. Fu, Q. W. Zhang, D. G. Remick, and R. L. Fairchild. 2001. Neutralization of Groa and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury. Am. J. Pathol. 159: 2137-2145.
22. Cugini, D., N. Azzollini, E. Gagliardini, P. Cassis, R. Bertini, F. Colotta, M. Noris, G. Remuzzi, and A. Benigni. 2005. Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusion. Kidney Int. 67: 1753-1761.
23. Fiorina, P., M. J. Ansari, M. Jurewicz, M. Barry, V. Ricchiuti, R. N. Smith, S. Shea, T. K. Means, H. Auchincloss, Jr., A. D. Luster, et al. 2006. Role of CXC chemokine receptor 3 pathway in renal ischemic injury. J. Am. Soc. Nephrol. 17: 716-723.
24. Furuichi, K., J. L. Gao, and P. M. Murphy. 2006. Chemokine receptor CX3CR1 regulates renal interstitial fibrosis after ischemia-reperfusion injury. Am. J. Pathol. 169: 372-387.
25. Oh, D. J., B. Dursun, Z. He, L. Lu, T. S. Hoke, D. Ljubanovic, S. Faubel, and C. L. Edelstein. 2008. Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice. Am. J. Physiol. Renal Physiol. 294: F264-F271.
26. Zlotnik, A., and O. Yoshie. 2012. The chemokine superfamily revisited. Immunity 36: 705-716.